CDC Updates Recommendations for COVID-19, Influenza, and RSV Vaccinations Ahead of 2025–26 Respiratory Virus Season

The Centers for Disease Control and Prevention (CDC) has released updated vaccination guidelines for the 2025–26 respiratory virus season, focusing on COVID-19, influenza, and respiratory syncytial virus (RSV). These recommendations aim to reduce the incidence of severe illness and hospitalizations associated with these viruses.

COVID-19 Vaccination: The CDC advises that individuals aged 6 months and older consult with healthcare providers regarding the updated COVID-19 vaccine. This approach emphasizes shared decision-making between patients and providers. The available vaccines include Pfizer for those aged 5 and older, Moderna for individuals 6 months and older, and Novavax for those aged 12 and older. These vaccines have been updated to target more recent strains of the virus and are accessible at most pharmacies, select doctors' offices, and certain public health departments. The optimal time for vaccination is in October or early November to ensure protection during the holiday season. For most insured individuals, the vaccine is covered; however, without insurance, the cost at retail pharmacies is approximately $220.

Influenza Vaccination: Annual flu vaccination is recommended for everyone aged 6 months and older. The CDC suggests receiving the flu shot by the end of October, with September and October being ideal months for vaccination. Flu vaccines are available at local pharmacies, doctors' offices, and public health departments. Additionally, AstraZeneca's FluMist, a nasal spray vaccine, is now available for home delivery in 34 states under the brand name FluMist Home. This option allows self-administration for adults under 50 and children as young as 2 with assistance from a caregiver. For those without insurance, the cost of a flu shot ranges from $30 for a regular dose to $130 for a high-dose vaccine recommended for individuals over 65.

RSV Vaccination: The CDC recommends a single dose of the RSV vaccine for adults aged 75 and older, as well as for those aged 50 to 74 who are at increased risk of severe illness. This vaccine provides protection against RSV-associated lower respiratory tract disease for at least two years. To protect infants, immunizations can be administered to mothers during pregnancy or to babies after birth as an antibody shot. The RSV vaccine is available for eligible adults at any time, with late summer and early fall being the optimal periods for vaccination. For pregnant individuals, the vaccine is typically available from September through January, while the antibody shot for infants is recommended from October through March. For those without insurance, the RSV vaccine may cost approximately $350, though patient assistance programs can help reduce out-of-pocket expenses.

Preventive Measures: In addition to vaccination, the CDC emphasizes the importance of preventive measures to reduce the spread of respiratory viruses. These include staying home when sick, avoiding crowded indoor locations during peak seasons, practicing good hand hygiene, covering the mouth when coughing, ensuring adequate sleep, and maintaining a healthy diet rich in fruits and vegetables. These strategies collectively contribute to minimizing the risk of infection and severe illness during the respiratory virus season.